Institut Claudius Regaud
Clinical trials sponsored by Institut Claudius Regaud, explained in plain language.
-
Sarcoma study: does Anti-Nausea pill change chemo levels?
Knowledge-focused CompletedThis study looked at how the anti-nausea drug aprepitant changes the amount of the chemotherapy drug ifosfamide in the blood of people with soft tissue sarcoma. 59 patients receiving standard chemotherapy (doxorubicin and ifosfamide) had their ifosfamide levels measured during th…
Phase: PHASE4 • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 01, 2026 16:03 UTC
-
Blood cell mystery in breast cancer: are they from tumors?
Knowledge-focused CompletedThis study looked at 60 people with metastatic breast cancer to find out if certain cells in their blood (called CK+/CD45+ double-positive cells) come from the tumor. Researchers took a blood sample before starting treatment and checked archived tumor samples. The goal was to bet…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
Scientists hunt for biomarkers to forecast melanoma treatment response
Knowledge-focused CompletedThis study involved 60 people with advanced melanoma who were already scheduled to receive immunotherapy (either a single drug or a combination). Researchers collected blood samples and, when possible, tumor samples before and during treatment to find markers that could predict w…
Phase: NA • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC
-
Blood markers may reveal breast cancer hormone sensitivity
Knowledge-focused CompletedThis study looked at whether tiny molecules called microRNAs in the blood can help doctors know if hormone therapy will work for women with advanced breast cancer. Researchers tested blood samples from 39 women before and after starting treatment with tamoxifen or aromatase inhib…
Phase: PHASE4 • Sponsor: Institut Claudius Regaud • Aim: Knowledge-focused
Last updated May 01, 2026 15:57 UTC